of whom 217 stated that they had with NCGS, whereas 1291 were diagnosed with CD, with otherwise comparable characteristics [4] . The data provided by the CD and NCGS participants were compared by using multivariate analysis. Interestingly as shown in summary table (condensed from tables 1-3 of the Rabinowitz paper [ Table 1 ]), the subset of subjects with NCGS differed significantly from CD patients with regard to six items. A minority of participants (~ 7 to 25%) did not believe information provided by established resources such as the US Food and Drug Administration, international professional gastroenterological societies, or nonprofit patient-centered celiac societies. A striking 30-35% of both groups rated online sources as the most reliable.
Overall, the paper further emphasizes the disparate beliefs of CD patients and of NCGS participants, the latter possibly with an a priori opposition to information derived from research conducted by the medical establishment [6] . Of interest, the authors correctly underscore the negative economic aspects of following a GFD due to its higher costs and to its possible medical ill effects if taken outside of a supervised medical setting, and also highlight the possible dire public health consequences of vaccine avoidance [7, 8] . 
